Showing results (381-390 of 654) with videos related to

Sort By:
Pageof 66
Lancet (London, England)|July 9, 1988
Genesis of breast cancer is in the premenopauseH W Simpson, W Candlish, A W Pauson, et al.
Biomaterials|April 25, 2003
Biological efficacy of electroless-deposited silver on plasma activated polyurethaneJ E Gray, P R Norton, R Alnouno, et al.
British Journal of Cancer|December 1, 1978
Relationship between oestrogen-receptor content and histological grade in human primary breast tumoursP V Maynard, C J Davies, R W Blamey, et al.
Pediatrics|February 2, 1999
Central nervous system manifestations of childhood shigellosis: prevalence, risk factors, and outcomeW A Khan, U Dhar, M A Salam, et al.
Pediatric Research|July 17, 2020
The newborn Fmr1 knockout mouse: a novel model of excess ubiquinone and closed mitochondrial permeability transition pore in the developing heartMatthew Barajas, Aili Wang, Keren K Griffiths, et al.
Cancer|September 1, 1990
EORTC protocol 30853: orchidectomy versus zoladex plus flutamide in the management of metastatic carcinoma of the prostate. Interim statistical analysis of the side effects of treatmentM R Robinson, L Denis, D W Newling, et al.
Revue D'Epidemiologie Et De Sante Publique|December 7, 2006
[Development and application of a clinical vignette to assess the quality of cancer care]L Cazale, D Tremblay, D Roberge, et al.
Vaccine|August 14, 2019
Household costs of seeking BCG vaccination in rural Guinea-BissauSanne M Thysen, Stine Byberg, Justiniano S D Martins, et al.
The Prostate|July 1, 1999
Finasteride in association with either flutamide or goserelin as combination hormonal therapy in patients with stage M1 carcinoma of the prostate gland. International Prostate Health Council (IPHC) Trial Study GroupR Kirby, C Robertson, A Turkes, et al.
Lancet (London, England)|August 11, 1979
Relationship of oestrogen-receptor status to survival in breast cancerH M Bishop, R W Blamey, C W Elston, et al.
Pageof 66